Dr. Lee Wayne Erlendson, MD

Dr. Erlendson practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Erlendson's NPI, 1962429886, was assigned on July 16, 2006. Dr. Erlendson graduated from Vanderbilt University School Of Medicine in 1980. Dr. Erlendson holds California license G50577.

Dr. Erlendson's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Erlendson also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Erlendson's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Erlendson to 1 more breast imaging center, 1 clinical lab, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Erlendson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erlendson practices, 5 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Erlendson's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Erlendson is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Erlendson's licenses on file in 2 states: California and Hawaii.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Erlendson treats.

CMS data shows 5,687 Medicare services from Dr. Erlendson across 27 procedure codes in 2024, for 492 Medicare patients. Medicare paid $1,288,584 for them.

CMS counts 492 Medicare patients who saw Dr. Erlendson in 2024. The largest group is 75 to 84, with 221 patients. 75% of them have arthritis, and 75% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erlendson's median patient age at 76, with 64% women.

In 2024, Dr. Erlendson wrote 3,109 Medicare Part D claims for 297 patients. 87% of them were for generic drugs. CMS names the drug for 2,968 of them, across 41 drugs with 11 or more claims each, at $362,668 in total drug cost. In 2023, CMS named 2,922 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Erlendson for performance year 2024, reported individually. Dr. Erlendson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Erlendson as offering telehealth.

CMS Open Payments shows 699 general payments to Dr. Erlendson from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Nevro Corp. paid the most, $3,608.

Dmand AI lists 2 awards for Dr. Erlendson, most recently CMS Stage 1 EHR in 2013.

Dr. Erlendson graduated from Vanderbilt University School Of Medicine in 1980.

Dr. Erlendson is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.